BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25867256)

  • 1. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
    Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
    Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
    Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.
    Roman E; Smith A; Appleton S; Crouch S; Kelly R; Kinsey S; Cargo C; Patmore R
    Cancer Epidemiol; 2016 Jun; 42():186-98. PubMed ID: 27090942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
    Li J; Smith A; Crouch S; Oliver S; Roman E
    Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
    Smith A; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
    Jayasekara H; Karahalios A; Juneja S; Thursfield V; Farrugia H; English DR; Giles GG
    Leuk Lymphoma; 2010 Mar; 51(3):456-68. PubMed ID: 20141433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Howell D; Smith A; Crouch S; Burton C; Roman E; Patmore R
    Eur J Cancer; 2017 Jun; 78():53-60. PubMed ID: 28412589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
    van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
    Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
    Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
    Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
    Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
    Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
    Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of lymphoma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016.
    Liu W; Liu J; Song Y; Zeng X; Wang X; Mi L; Cai C; Wang L; Ma J; Zhu J; ;
    J Hematol Oncol; 2019 Nov; 12(1):115. PubMed ID: 31744509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
    Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification.
    Monabati A; Safaei A; Noori S; Mokhtari M; Vahedi A
    Ann Hematol; 2016 Mar; 95(4):613-8. PubMed ID: 26754635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.
    Marcos-Gragera R; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Maynadie M; Luminari S; Ferretti S; Johannesen TB; Sankila R; Karjalainen-Lindsberg ML; Simonetti A; Martos MC; Raphaël M; Giraldo P; Sant M;
    Haematologica; 2011 May; 96(5):720-8. PubMed ID: 21330324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
    Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
    Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.